Is PRM or CBT a better buy right now?

Based on our latest analysis, CBT is currently the stronger investment candidate based on our comprehensive scoring model.

Does PRM or CBT have better growth?

Our analysis compares revenue and earnings growth. Check the 'Growth' section above to see which company is expanding faster. Typically, the stock with higher revenue growth rates is considered the better growth stock.

Which stock is cheaper: PRM or CBT?

We compare P/E ratios and other valuation metrics in the 'Valuation' section. The stock with the lower P/E ratio is generally considered 'cheaper' relative to its earnings, though growth prospects must also be considered.

Which is the better buy right now, PRM or CBT?

As of Nov 11, 2026, CBT scores higher in our model: PRM has an AI score of 32.2 versus 47.6 for CBT. PRM is currently in a Neutral technical phase and CBT is in a Markdown phase. Consider both scores and phases alongside your own risk tolerance.

What technical phase are PRM and CBT in?

PRM is in a Neutral phase (Hold) with an RSI of 62.4. CBT is in a Markdown phase (Sell / avoid) with an RSI of 42.6.

PRM vs CBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

PRM

32.2

AI Score

CBT Wins

CBT

47.6

AI Score

Investment Advisor Scores

PRM

32score

Recommendation

SELL

View Full Analysis

CBT

48score

Recommendation

HOLD

View Full Analysis

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric	PRM	CBT	Winner
Revenue	728.74M	2.73B	CBT
Net Income	195.77M	147.00M	PRM
Gross Margin	55.9%	22.1%	PRM
Net Margin	26.9%	5.4%	PRM
Operating Income	285.92M	356.00M	CBT
ROE	14.7%	9.2%	PRM
ROA	5.8%	3.7%	PRM
Total Assets	3.40B	3.98B	CBT
Cash	115.91M	250.00M	CBT
Debt/Equity	0.91	0.52	CBT
Current Ratio	2.79	1.47	PRM
Free Cash Flow	42.30M	126.00M	CBT

Relative Price Performance (Last 90 Days)

PRM 1M: +11.5% · 3M: -9.2% CBT 1M: -4.3% · 3M: -16.3%

Current Technical Phase

PRM

Neutral

Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.4 · Price: $30.67

CBT

Markdown

Sell / avoid

Price below a falling SMA50 (slope -5.7%), weak momentum, RSI 43

RSI (14): 42.6 · Price: $72.23

Fundamentals Snapshot

Metric	PRM	CBT
Market Cap	—	—
Forward P/E	17.9	9.4
Trailing P/E	139.6	18.0
Revenue (TTM)	—	—
Revenue Growth	0.2%	0.1%
Gross Margin	0.5%	0.2%
Operating Margin	1.1%	0.1%
EPS	0.22	4.02
Dividend Yield	—	0.00%

Frequently Asked Questions

Based on our detailed analysis, CBT is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.

Related Analysis

PRM

CBT

Data derived from SEC EDGAR filings and Tradestie proprietary analysis. Last updated: Nov 11, 2026 21:41 UTC. Refresh Data

Tradestie